Polypharmacy and major adverse events in atrial fibrillation. Tsagkaris C, Papazoglou AS, Kartas A, Samaras A, et al. J Cardiovasc Pharmacol 2022 Jul 29. pii: 00005344-990000000-00089.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsagkaris C, Papazoglou AS, Kartas A, Samaras A, et al. Polypharmacy and major adverse events in atrial fibrillation. J Cardiovasc Pharmacol 2022 Jul 29. pii: 00005344-990000000-00089.
PMID: 35921643